Afleveringen
-
From gene and cell therapies, to the use of CRISPR and other precision engineering technologies, this episode dives into the opportunities and challenges of the emerging field of advanced therapies.
On Discovery Matters this week, Dodi and Conor are joined by Daria Donati, Chief Scientific Officer of Genomic Medicine at Cytiva, as well as Jen Moody, Vice President of External Innovation of Genomic Medicines at Danaher, to discuss the science, progress, and potential of advanced therapeutics.
Demaris Mills, Group Executive of Genomic Medicines at IDT, and experts Fyodor Urnov, Professor of Molecular and Cell Biology at the University of California, Berkeley, and the Director of Technology & Translation at the Innovative Genomics Institute, cover the technologies used in gene and cell therapies as well as CRISPR to deliver powerful and precise treatments aiming for a healthier future.
-
Can you tell the difference between a human and AI? Of course you can…right? We challenge Conor and Dodi to tell the difference between Conor and Conor BOT all while uncovering how AI is transforming the life sciences.
Uncover how AI is transforming the life sciences. Together with an AI-bot the pair explore the potential applications of AI in drug discovery, personalizing medical treatments, protein folding, and more. They also consider the ethical considerations required when developing AI models, as well as the need for emotional intelligence in AI systems.
Keywords: AI, ethical dilemma, bias, misinformation, datasets, diagnostics, drug discovery, healthcare.
-
Zijn er afleveringen die ontbreken?
-
Let's explore the remarkable colour-changing abilities of cephalopods. Joined by Dan Wilson from the Kostas Research Institute at Northeastern University, the team dive into the fascinating research behind the development of paints that respond to environmental stimuli, such as sunlight. They also discuss titanium dioxide and how it acts as a facilitator of the colour-changing process. Professor Alon Gorodetsky, Associate Professor of Chemical and Biomolecular Engineering at the University of California, Irvine, talks about his research on developing energy-responsive dyes to mimic the features of octopi. Discover the potential applications of these dyes from diagnostics to resource-constrained initiatives, and more. Listen in and discover this remarkable evolutionary adaptation and the incredible ingenuity of cephalopods.
-
In this episode of Discovery Matters, hosts Dodi and Conor explore how synthetic biology can lead to transformative breakthroughs when it comes to dealing with global health problems. Through their conversation with Justin Vigar, a PhD student in Dr. Keith Pardee's lab at the University of Toronto in Canada, we learn how his team's paper-based diagnostic tool has the potential to provide faster, more cost-efficient, and accessible diagnostics for underserved locations. This is complemented by Amir Pandi and Tobi Erb's discussion of using AI and synthetic biology to develop new antimicrobial peptides.
Show notes
• U of T PhD student uses synthetic biology to create low-cost diagnostic tools.
• Pandi, A., Adam, D., Zare, A. et al. Cell-free biosynthesis combined with deep learning accelerates de novo-development of antimicrobial peptides. Nat Commun 14, 7197 (2023). https://doi.org/10.1038/s41467-023-42434-9
• Khalek IS, et al. Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxins. Sci Transl Med. 2024 Feb 21;16(735). https://doi.org/10.1126/scitranslmed.adk1867
• Josh A Goldstein, Jason Chao, Shelby Grossman, Alex Stamos, Michael Tomz, How persuasive is AI-generated propaganda?, PNAS Nexus, Volume 3, Issue 2, February 2024. https://doi.org/10.1093/pnasnexus/pgae034
-
Tune in to Discovery Matters to see how we can drug the undruggable. Dodi and Conor talk to Mark Bray, a second year PhD student in the Bowman Lab at the University of Pennsylvania, about the concept of “drugging the undruggable” for drug discovery and development. They discuss advances in medical research which has enabled us to drug molecular targets that were previously inaccessible, and the strategies that are used to devise and find effective drugs. Vicky Richon, CEO at Entact Bio, elucidates the importance of a revolutionary “induced proximity” modality for unprecedented drug treatments. Listen to this episode to understand modern approaches to treating diseases and uncovering cures.
-
Explore the potential of artificial intelligence (AI) and machine learning to revolutionize biomedical research and make personalized healthcare a reality.
Tune in to Discovery Matters to see how AI and machine learning will be the future of biomedical research. Featuring interviews with Professor Kourosh Saeb-Parsy and Dr Namshik Han — leaders in the AI and biotech space — this episode delves into the significance of advanced technology for unlocking discoveries in transplantation, understanding the causes of diseases, precision medicine, and more.
Show notes:
This AI learnt language by seeing the world through a baby’s eyes
Computational phylogenetics reveal histories of sign languages
-
Let’s explore the world of antibody drug conjugates (ADCs) and their potential for improving human health. Our two guests—Principal Investigator Sasha Ebrahimi from GSK and oncologist Dr. Paolo Tarantino—discuss the development and advantages of ADCs, and how they can be used to personalize treatments for cancer and other illnesses. Sasha explains how ADCs combine the targeting capabilities of antibodies with the cytotoxic effects of drugs, while Dr. Tarantino delves into his research with breast cancer and immunotherapies. Learn more about the possibilities of ADCs in this insightful episode of Discovery Matters.
Keywords: antibody drug conjugates, adc, chemotherapy, antibodies, cancer, oncology, patient, breast cancer.
-
Discovery Matters is back with our best episodes and insights from the past year. Dodi and Conor re-explore some cutting-edge ideas and technologies pushing the frontiers of science and medicine forward. We look back on some of our favorite episodes including therapies such as psychedelic drugs, the sentience of brain cells, and the potential of marine microbes to fight cancer. They explore the potential of DNA to create medicine, the use of organoids in drug testing, and the use of cryopreservation for cell therapies. Join us as we uncover newer and better ways of improving health through science. Find out why Discovery Matters to you and the world by tuning into this episode.
-
Join Conor and Dodi in the latest episode of Discovery Matters, as they explore the wonders of ground-breaking scientific discoveries from multidisciplinary collaboration. MIT's Professor Pete Dedon expresses how multidisciplinary approaches and unique combinations of experiences can help to produce unexpected results. Professor James Evans of the University of Chicago then brings in the concept of surprise and hypergraphs to uncover the connections between different fields of knowledge. With insights from their guests, the latest episode of Discovery Matters dives deep into the mechanics behind groundbreaking discoveries. Jump in and listen to discover new ways to think about innovations and uncover the next amazing breakthrough!
Keywords: multidisciplinary, ideas, papers, surprise, science, combinations, teams, antibiotics, compounds, infectious diseases, malaria, space, serendipity.
-
Let’s explore the world of organoids and their potential to revolutionize disease treatment. Joined by Matthias Zilbauer and Roisin Owens, we look at the interplay of the gut-brain axis with organic electronic materials. Dive into the advances in organoid and microbial models used to develop treatments for illnesses such as Irritable Bowel Syndrome (IBS), Crohn’s Disease, and Ulcerative Colitis. Join Dodi and Conor to discover how bioengineering could change our understanding of health and disease - and our lives.
Transcript
Show notes
Shi, F., Evans, J. Surprising combinations of research contents and contexts are related to impact and emerge with scientific outsiders from distant disciplines. Nat Commun 14, 1641 (2023). https://doi.org/10.1038/s41467-023-36741-4.
Moon landing: India’s home-grown tech cut the costs (nature.com)
Keywords: microbiome, patient, model, cells, tissue, disease, gut, biological systems, microbes, biology, pediatric gastroenterology, science, organoids
-
In this episode of Discovery Matters, we discuss the exciting potential of lipid nanoparticles (LNPs) to deliver genetic material and therapeutics to target cells and tissues. We are joined by Lloyd Jeffs, Senior Director of Biopharma Services at Precision NanoSystems, and Prof Dan Peer, Director of the Laboratory of Precision Nanomedicine at Tel Aviv University. Dan shares how his team has developed siRNA LNPs to deliver treatment more efficiently for ovarian cancer patients. From Dan's unique perspective, learn why this technology is cutting-edge, and why it may help defeat one of mankind’s biggest enemies— cancer.
Transcript
Show notes
Therapeutic gene silencing of CKAP5 leads to lethality in genetically unstable cancer cells | Science Advances
Neuroscientists decoded a Pink Floyd song using people’s brain activity (sciencenews.org)
Nutrients | Free Full-Text | Does Pizza Consumption Favor an Improved Disease Activity in Rheumatoid Arthritis? (mdpi.com)
Keywords: ovarian cancer, nanoparticles, lipid nanoparticles, genomic medicine, tumour, nucleic acids, cells, chemotherapy, drug, mrna, patients, sirna, rna.
-
Challenges of improving access to healthcare in developing countries - it's a conversation we need to have. With the help of Dr Jerome Kim, Director General of the International Vaccine Institute, we discuss vaccination and immunization programs as a key aspect of public health and global development – especially in developing nations, where access to life-saving medicines is often limited or non-existent. Karen Heichman, Deputy Director of Diagnostics, Bill and Melinda Gates Foundation, takes us on a journey of the critical role of diagnostics in the fight against diseases.Tune in to hear how technology and innovation could help to bridge the gap in access to healthcare and potentially save lives in the process.
-
Through a discussion of combination therapies, Dodi and Conor delve into the mysterious power of the human microbiome, and antimicrobial resistance. With evidence of the microbiome being a key factor in fighting diseases, this episode highlights the importance of understanding and treating the microbiome and its potential to improve lives. Tune in to find out more and explore the possibilities of the microbiome with Dr Saman Maleki, and the power of serendipity with Prof Pete Dedon!
Transcript
Show notes
Routy, B., Lenehan, J.G., Miller, W.H. et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat Med 29, 2121–2132 (2023).
A novel combination therapy counters antibiotic-resistant Mycobacterium abscessus infections (MIT news)
'Blight' warns that a future pandemic could start with a fungus (sciencenews.org)
Hildebrandt, T., Peyser, D. The gut microbiome in anorexia nervosa. Nat Microbiol 8, 760–761 (2023).
Keywords: microbiome, patients, immunotherapy, immune system, cancer, study, people, combination therapy, tumor, immuno-oncology, fungus, fecal transplant, anorexia nervosa, oncology, higher bmi
-
In this episode, we dive into the potential of liquid biopsies as a method to detect deadly diseases. We speak with three experts – Marta Herreros, Rik Bryan, and Doug Ward – to learn more about the non-invasive nature of liquid biopsies and the process of detecting biomarkers within a patient sample. Rik and Doug discuss their GALEAS Bladder test, which can identify key mutations present in 96% of bladder cancer patients. Tune in to learn more about the potential of liquid biopsies and the importance of early detection!
Transcript
Show notes
GALEAS Bladder test – Galeas Bladder BBC and hybrid working – Internal Communications Europe 2023 — BBC Identification by ears – Ear identification: A multi-ethnic study sample - ScienceDirectKeywords: bladder cancer, patient, liquid biopsy, urine, cells, bladder, urine test, urine sample, mutations, tumor, DNA, cancer, clinical trials, sequencing, samples, biomarkers.
-
Why do China and US have different government regulations? Why can’t we do business above the fray?
These are just some of the struggles biopharma executives report impacting their business. Our guests are of the same view – the industry needs fixing.
Yingke He, CEO and Co-Founder of Forecyte Bio, explains how China's industrialized experience is limited and in its early stages compared to the US.
Listen to this episode to understand the industry tensions and areas showing promise.
Transcript
Show notes
The Biopharma Resilience Index - Biopharma Resilience | Cytiva (cytivalifesciences.com)
Pessimists Archive - Pessimists Archive
Caesarean babies and their mother’s microbiome - 'Vaginal seeding' boosts the development of babies born by C-section | New Scientist
Keywords: talent, industry, manufacturing, collaboration, pandemic, therapies, challenges, government, regulators, biopharma resilience index, policies, solutions, companies, China, genomic medicine, cell and gene therapy.
-
In this episode of Discovery Matters, we explore the incredible advances in precision medicine enabled by organoid technology. Vicky Marsh Durban and Oksana Sirenko contribute to the conversation, talking about how machine learning and robotics are used to scale up organoid culture and analyse data, as well as the potential of organoids to revolutionise regenerative medicine. Listen to this episode for an insightful and informative deep dive into the potential of organoids for transforming the face of modern medicine.
Transcript
Keywords: patient, cells, tissues, cardiac, drugs, assays, cancer, organoids, data, technology, stem cells, tumors, automation, ai.
-
War! What is it good for? In this episode of Discovery Matters, Dr Smith explains how military medicine first shaped state medicine and how wartime creates an opportunity to innovate. From advances in prosthetics, psychology, and cosmetic surgery to the mass production of penicillin during World War II, this episode dives deep into the life-saving innovations brought over the line due to conflicts.
Show notes
More is Better: English Language Statistics are Biased Toward Addition - Winter - 2023 - Cognitive Science - Wiley Online Library Protecting maternal health in Rwanda | MIT News | Massachusetts Institute of TechnologyTranscript
Keywords: medicine, war, military, wartime, innovation, doctors, civilian, patient, ai, medical, human, diseases, historian, psychiatry, navy, history.
-
John Morris, a scientist at the forefront of cryopreservation technology, joins Dodi and Conor. They discuss the impact of cryopreservation on the development of CAR T therapies, why freezing cells is essential to these treatments, how tracking the samples ensures quality, and the potential for frozen cells to treat solid tumors in the future. Tune in to find out how cryopreservation has transformed the life sciences and how it could revolutionize how we treat disease in the future.
Show notes
Pioneers and Visionaries docu-series.
Transcript
Keywords: patient, cells, freezing, therapies, gene therapy, car t, t cells, john Morris, cytiva, podcast, stabilizing, cryogenics, cold chain
-
Conor and Dodi explore the new and exciting world of bacteriophage therapy. Join them as they speak to Anton Peleg, Professor of Infectious Diseases and Microbiology and the Director of the Department of Infectious Diseases at the Alfred Hospital and Monash University, about this emerging field. Together they discuss how phages, viruses that specifically target bacteria, are being used to fight against antibiotic-resistant superbugs and the challenges of producing them at scale and getting them approved by regulatory bodies.
Show notes
For more information on Professor Anton Peleg’s work with phages: Old cure revived in fight against antibiotic-resistant superbugs (smh.com.au)
RNA in space: Oba, Y., Koga, T., Takano, Y. et al. Uracil in the carbonaceous asteroid (162173) Ryugu. Nature Communications 14, 1292 (2023). https://doi.org/10.1038/s41467-023-36904-3
Transcript
Keywords: phage, bacteria, infection, antibiotics, rna, therapies, bacterial infections, penicillin, patients, antibiotic resistant bacteria, cholera, phage therapy, superbugs.
-
In the latest episode of Discovery Matters, Dodi and Conor are joined by Dr. Bradley Moore from the Scripps Institution of Oceanography to discuss his research into the medical and synthetic implications of using marine microbes to fight aggressive cancers such as glioblastoma. By leveraging salinosporamide A, Dr. Moore proposes that these deep-sea organisms could potentially be scaled up for human use and repurposed for medicinal and synthetic purposes. Dive into this episode to hear how the ocean has the power to bring forth new discoveries that could save lives!
Show notes
For more information on this 'anti-cancer weapon': Scientists Discover How Molecule Becomes Anticancer Weapon | Scripps Institution of Oceanography (ucsd.edu)
Transcript
Keywords: glioblastoma, salinosporamide A, Scripps, chemicals, organisms, coral, ocean, genomes, dna, molecules, medicine, bacterium, drug, oceanography, sequence, sea.
- Laat meer zien
